Stocks and Investing Stocks and Investing
Thu, July 29, 2021

Elliot Wilbur Maintained (TEVA) at Buy with Decreased Target to $14 on, Jul 29th, 2021


Published on 2024-10-27 17:22:54 - WOPRAI, Elliot Wilbur
  Print publication without navigation


Elliot Wilbur of Raymond James, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Buy with Decreased Target from $15 to $14 on, Jul 29th, 2021.

Elliot has made no other calls on TEVA in the last 4 months.



There is 1 other peer that has a rating on TEVA. Out of the 1 peers that are also analyzing TEVA, all agrees with Elliot's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kevin Caliendo of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $11 on, Tuesday, May 4th, 2021
Contributing Sources